Individual investors like stocks with a high growth potential. These companies have a strong outlook that can bring a significant upside to your portfolio, regardless of market cyclicality. I would suggest taking a look at my list of companies that compare favourably in all criteria, and consider whether they would add value to your current portfolio.
Sharda Motor Industries Limited (BSE:535602)
Sharda Motor Industries Limited manufactures, assembles, and sells auto components and white goods components in India. Formed in 1986, and currently headed by CEO Ajay Relan, the company provides employment to 1,165 people and with the company’s market capitalisation at INR ₹13.46B, we can put it in the large-cap group.
Extreme optimism for 535602, as market analysts projected an outstanding earnings growth rate of 21.17% for the stock, supported by a double-digit sales growth of 34.81%. It appears that 535602’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 20.39%. 535602’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Want to know more about 535602? Have a browse through its key fundamentals here.
Shivalik Bimetal Controls Limited (BSE:513097)
Shivalik Bimetal Controls Limited engages in process and product engineering business in India. Started in 1984, and run by CEO Narinder Ghumman, the company currently employs 265 people and with the company’s market capitalisation at INR ₹4.66B, we can put it in the mid-cap stocks category.
513097 is expected to deliver a buoyant earnings growth over the next couple of years of 29.15%, bolstered by an equally impressive revenue growth of 50.56%. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a positive return on equity of 16.51%. 513097’s impressive outlook on all aspects makes it a worthy company to spend more time to understand. Could this stock be your next pick? Other fundamental factors you should also consider can be found here.
Abbott India Limited (BSE:500488)
Abbott India Limited operates as a pharmaceutical company in India. Formed in 1944, and currently run by Ambati Venu, the company employs 2,700 people and with the company’s market cap sitting at INR ₹120.43B, it falls under the large-cap category.